Abstract
5-HT(1A) receptor and α(1)-adrenoreceptor (α(1)-AR) binding sites recognized by the 1,4-dioxanes 2-4 display reversed stereochemical requirements. (S)-2 proved to be a potent 5-HT(1A) receptor agonist highly selective over α(1)-AR subtypes. Chirality influenced the anticancer activity of 3 and 4 in human prostate cancer cells (PC-3): (R)-4, eutomer at the α(1d)-AR subtype, was the most potent. The decreased effect of 4 and (R)-4 in α(1d)-AR silenced PC-3 cells confirmed that their anticancer activity was α(1d)-AR-dependent.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Binding Sites
-
Cell Line
-
Dioxanes / chemistry
-
Dioxanes / pharmacology*
-
Humans
-
Magnetic Resonance Spectroscopy
-
Receptor, Serotonin, 5-HT1A / metabolism*
-
Receptors, Adrenergic, alpha-1 / drug effects*
-
Receptors, Adrenergic, alpha-1 / metabolism
-
Receptors, Serotonin, 5-HT1 / drug effects*
-
Receptors, Serotonin, 5-HT1 / metabolism
-
Stereoisomerism
-
Structure-Activity Relationship
Substances
-
Dioxanes
-
Receptors, Adrenergic, alpha-1
-
Receptors, Serotonin, 5-HT1
-
Receptor, Serotonin, 5-HT1A
-
1,4-benzodioxan